LON:AVO

Advanced Oncotherapy - AVO Share Forecast, Price & News

GBX 16.75

-0.25 (-1.49%)

(As of 12/8/2022 04:05 AM ET)

Add

Compare

Today's Range: 16.51
▼
16.75
50-Day Range: 16.50
▼
24.50
52-Week Range: 16.50
▼
40

Volume: 1,890 shs
Average Volume: 286,135 shs
Market Capitalization: £89.01 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Advanced Oncotherapy (LON:AVO) Stock

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

October 27, 2022 | proactiveinvestors.com

Proactive news headlines: Deepverge, Greatland Gold, Seeing Machines, and more

September 29, 2022 | uk.finance.yahoo.com

Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved

September 8, 2022 | finance.yahoo.com

Advanced Oncotherapy plc (LON:AVO) has caught the attention of institutional investors who hold a sizeable 39% stake

August 1, 2022 | finance.yahoo.com

Is Now An Opportune Moment To Examine Advanced Oncotherapy plc (LON:AVO)?

July 2, 2022 | finance.yahoo.com

Calculating The Intrinsic Value Of Advanced Oncotherapy plc (LON:AVO)

March 31, 2022 | proactiveinvestors.com

Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEO

March 26, 2022 | proactiveinvestors.com.au

Proactive weekly mining highlights: Horizonte, Atlantic Lithium, East Star and more

March 25, 2022 | proactiveinvestors.com

Advanced Oncotherapy raises £2mln at a premium

March 1, 2022 | proactiveinvestors.com

FTSE 100 in the red as fighting in Ukraine is intensifying with Russia

March 1, 2022 | proactiveinvestors.com

Advanced Oncotherapy hails significant progress with regulatory submission as it updates on its timeline

February 25, 2022 | finance.yahoo.com

Advanced Oncotherapy plc (AVO.L)

December 13, 2021 | proactiveinvestors.com

Advanced Oncotherapy says it is making good progress, but confirms previously-flagged delay

November 15, 2021 | markets.businessinsider.com

Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight

October 2, 2021 | finance.yahoo.com

Is Advanced Oncotherapy plc (LON:AVO) Popular Amongst Insiders?

September 2, 2021 | proactiveinvestors.com

Advanced Oncotherapy - Result of GM, TVR and clarification re warrants

August 12, 2021 | markets.businessinsider.com

Advanced Oncotherapy : Result of AGM

August 12, 2021 | finanznachrichten.de

Hardman & Co Research: Advanced Oncotherapy (AVO) Funded to completion

August 11, 2021 | proactiveinvestors.com

Advanced Oncotherapy - Proposed subscription and issuance of shares

June 30, 2021 | proactiveinvestors.com

Advanced Oncotherapy says 2021 to be important year

June 3, 2021 | proactiveinvestors.com

Advanced Oncotherapy signs initial deal to provide LIGHT system treatment rooms for £75.5mln

May 29, 2021 | markets.businessinsider.com

Advanced Oncotherapy : Total Voting Rights

March 22, 2021 | proactiveinvestors.com

Advanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers'

March 12, 2021 | lse.co.uk

Advanced Oncotherapy study shows superiority of Light for cancers

March 12, 2021 | proactiveinvestors.com

Advanced Oncotherapy shows potential to treat resistant cancers

February 17, 2021 | finance.yahoo.com

What Type Of Shareholders Make Up Advanced Oncotherapy plc's (LON:AVO) Share Registry?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Company Calendar

Last Earnings: 6/29/2020
Today: 12/08/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:AVO
CUSIP: N/A
CIK: N/A
Web: www.advancedoncotherapy.com
Phone: +44-20-36178728
Fax: N/A
Employees: 139
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 98.71
Current Ratio: 1.26
Quick Ratio: 0.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.49 per share
Price / Cash Flow: 34.00
Book Value: GBX 13.60 per share
Price / Book: 1.23

Miscellaneous

Outstanding Shares: 531,481,000
Free Float: N/A
Market Cap: £89.01 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Michael Jeffrey Sinclair (Age 79)
Exec. Chairman
Comp: $434.42k

Mr. Nicolas Serandour
CEO & Exec. Director

Prof. Stephen Myers OBE (Age 75)
Exec. Director
Comp: $397.72k

Mr. Ed Lee
COO & Pres of Europe

Mr. Graham Pughe
Sr. Vice-Pres of Accounting

Ms. Berengere Pons-Chabord
Sr. Vice-Pres of Corp. Fin.

Dr. Manuel Gallas
Director of Technical & Engineering

Mr. David Navas
VP of Investor and PR

Ms. Bridget Biggar
Director of HR

Ms. Donatella Ungaro
Managing Director of ADAM

Key Competitors

View All Competitors

Insiders & Institutions

Enrico Cipro Vanni
Bought 100,000 shares on 3/2/2022
Total: £2.60 M ($26.00/share)

View All Insider Transactions
View All Institutional Transactions

AVO Stock - Frequently Asked Questions

How have AVO shares performed in 2022?: Advanced Oncotherapy's stock was trading at GBX 38 on January 1st, 2022. Since then, AVO shares have decreased by 55.3% and is now trading at GBX 17.
View the best growth stocks for 2022 here.
How were Advanced Oncotherapy's earnings last quarter?: Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.
What other stocks do shareholders of Advanced Oncotherapy own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).
What is Advanced Oncotherapy's stock symbol?: Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy?: Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Advanced Oncotherapy's stock price today?: One share of AVO stock can currently be purchased for approximately GBX 17.
How much money does Advanced Oncotherapy make?: Advanced Oncotherapy (LON:AVO) has a market capitalization of £90.35 million.
How many employees does Advanced Oncotherapy have?: The company employs 139 workers across the globe.
How can I contact Advanced Oncotherapy?: Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The official website for the company is www.advancedoncotherapy.com. The company can be reached via phone at +44-20-36178728.

This page (LON:AVO) was last updated on 12/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial